{
  "timestamp": "2025-12-17T11:23:39.311188",
  "data": {
    "trials": {
      "summary": {
        "active": 4,
        "completed": 1,
        "phase_distribution": {
          "Observational": 0,
          "Phase 1": 0,
          "Phase 2": 0,
          "Phase 3": 2,
          "Phase 4": 1
        }
      },
      "details": [
        {
          "trial_id": "NCT04715113",
          "title": "Hemodynamic Effects of Acute Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension: Single-center Randomized Controlled Trial",
          "status": "Completed",
          "phase": "NA",
          "sponsor": "University of Zurich",
          "locations": [
            "Switzerland"
          ],
          "start_date": "2021-02-01",
          "end_date": "2023-05-31"
        },
        {
          "trial_id": "NCT03460470",
          "title": "Sildenafil in US Heart Failure Patients (SilHF-US)",
          "status": "Active",
          "phase": "Phase 3",
          "sponsor": "Hartford Hospital",
          "locations": [
            "United States"
          ],
          "start_date": "2018-02-14",
          "end_date": "2018-12"
        },
        {
          "trial_id": "NCT01616381",
          "title": "Sildenafil in Heart Failure (SilHF); An Investigator Initiated Multinational Randomized Controlled Clinical Trial.",
          "status": "Active",
          "phase": "Phase 3",
          "sponsor": "Helse Stavanger HF",
          "locations": [
            "Israel",
            "Italy",
            "Norway",
            "United Kingdom"
          ],
          "start_date": "2013-03",
          "end_date": "2019-12"
        },
        {
          "trial_id": "NCT01582438",
          "title": "A Local, Multicentre, Open Label Access Study, To Provide Sildenafil Therapy For Subjects Who Completed A1481156 Study And Are Judged By The Investigator To Derive Clinical Benefit From Continued Treatment With Sildenafil For Subjects In India",
          "status": "Active",
          "phase": "Unknown",
          "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.",
          "locations": [
            "India"
          ],
          "start_date": "Not available",
          "end_date": "Not available"
        },
        {
          "trial_id": "NCT03053739",
          "title": "Randomized Controlled Trial to Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic Sclerosis",
          "status": "Active",
          "phase": "Phase 4",
          "sponsor": "Post Graduate Institute of Medical Education and Research, Chandigarh",
          "locations": [
            "India"
          ],
          "start_date": "2016-12",
          "end_date": "2017-12"
        }
      ],
      "notes": "Parsed deterministically from ClinicalTrials.gov"
    }
  }
}